Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Sales (2016 - 2025)

Historic Return on Sales for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to 6.8%.

  • Firefly Neuroscience's Return on Sales rose 1231700.0% to 6.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.39%, marking a year-over-year increase of 265700.0%. This contributed to the annual value of 0.67% for FY2023, which is 3600.0% up from last year.
  • Firefly Neuroscience's Return on Sales amounted to 6.8% in Q3 2025, which was up 1231700.0% from 6.13% recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Return on Sales ranged from a high of 68.82% in Q4 2024 and a low of 300.7% during Q1 2025
  • Over the past 5 years, Firefly Neuroscience's median Return on Sales value was 0.52% (recorded in 2021), while the average stood at 22.59%.
  • In the last 5 years, Firefly Neuroscience's Return on Sales tumbled by -1285600bps in 2024 and then soared by 1231700bps in 2025.
  • Firefly Neuroscience's Return on Sales (Quarter) stood at 0.52% in 2021, then crashed by -715bps to 4.26% in 2022, then skyrocketed by 98bps to 0.08% in 2023, then soared by 86672bps to 68.82% in 2024, then crashed by -110bps to 6.8% in 2025.
  • Its Return on Sales was 6.8% in Q3 2025, compared to 6.13% in Q2 2025 and 300.7% in Q1 2025.